Mesalamine
NDC 0591-2245, Mesalamine, tablet, delayed release, from Actavis Pharma, Inc..
- Product NDC
- 0591-2245
- Status
- Listed
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203817
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2245 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MESALAMINE1.2 g/1
Pharmacologic classes
Aminosalicylate [EPC]; Aminosalicylic Acids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0591-2245-22 | 00591224522 | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (0591-2245-22) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ba1e3bd4-fbe0-46a5-961e-167ccb09672cNADAC price for package 00591224522
GET /v1/drugs/nadac/00591224522
Use it
Look up 0591-2245 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2245 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0591-2245. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.